Ready, our operational intelligence and workforce readiness platform, received a very warm welcome from the clinical trials industry at the DIA 2019 Global Annual Meeting.
During the Meeting, I was invited to join PharmaVoice to discuss how Ready analyzes behavioral data to enable Sponsors, CROs, and other trial stakeholders to evaluate and improve the readiness of their workforce and sites.
The video below includes highlights from our discussion.
If you are interested in learning more about Ready and how ArcheMedX is mitigating trial risk, please contact our team to schedule a capabilities presentation or demo.
Thank you again to Taren Grom and the PharmaVoice team for sharing this interview.
Related Post
The Earliest Warning Sign: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
Most protocol deviations start as human problems, not operational ones, but risk-based monitoring typically relies…
Brian S McGowan, PhD
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
By leveraging the Fresh Start Effect at site initiation and shifting from passive training to…
Brian S McGowan, PhD
The Confidence Trap in Clinical Trials: When Knowing Just Enough Becomes Dangerous
Ways to identify false certainty, or "errogance," during the clinical site start-up-to-launch process—and better ensure…
